264 related articles for article (PubMed ID: 32146226)
1. The ADNEX model to triage adnexal masses: An external validation study and comparison with the IOTA two-step strategy and subjective assessment by an experienced ultrasound operator.
Viora E; Piovano E; Baima Poma C; Cotrino I; Castiglione A; Cavallero C; Sciarrone A; Bastonero S; Iskra L; Zola P
Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():207-211. PubMed ID: 32146226
[TBL] [Abstract][Full Text] [Related]
2. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
[TBL] [Abstract][Full Text] [Related]
3. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
[TBL] [Abstract][Full Text] [Related]
4. Subjective assessment and IOTA ADNEX model in evaluation of adnexal masses in patients with history of breast cancer.
Pozzati F; Sassu CM; Marini G; Mascilini F; Biscione A; Giannarelli D; Garganese G; Fragomeni SM; Scambia G; Testa AC; Moro F
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):594-602. PubMed ID: 37204769
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of IOTA Simple Rules, IOTA ADNEX Model, RMI, and Subjective Assessment for Preoperative Adnexal Mass Evaluation: The Experience of a Tertiary Care Referral Hospital.
Vilendecic Z; Radojevic M; Stefanovic K; Dotlic J; Likic Ladjevic I; Dugalic S; Stefanovic A
Gynecol Obstet Invest; 2023; 88(2):116-122. PubMed ID: 36716716
[TBL] [Abstract][Full Text] [Related]
6. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
Hiett AK; Sonek JD; Guy M; Reid TJ
Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
[TBL] [Abstract][Full Text] [Related]
7. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group.
Timmerman D; Ameye L; Fischerova D; Epstein E; Melis GB; Guerriero S; Van Holsbeke C; Savelli L; Fruscio R; Lissoni AA; Testa AC; Veldman J; Vergote I; Van Huffel S; Bourne T; Valentin L
BMJ; 2010 Dec; 341():c6839. PubMed ID: 21156740
[TBL] [Abstract][Full Text] [Related]
8. Two-Step Strategy for Optimizing the Preoperative Classification of Adnexal Masses in a University Hospital, Using International Ovarian Tumor Analysis Models: Simple Rules and Assessment of Different NEoplasias in the adneXa Model.
Esquivel Villabona AL; Rodríguez JN; Ayala N; Buriticá C; Gómez AC; Velandia AM; Rodríguez N; Alcázar JL
J Ultrasound Med; 2022 Feb; 41(2):471-482. PubMed ID: 33890698
[TBL] [Abstract][Full Text] [Related]
9. Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center.
Araujo KG; Jales RM; Pereira PN; Yoshida A; de Angelo Andrade L; Sarian LO; Derchain S
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):778-783. PubMed ID: 27194129
[TBL] [Abstract][Full Text] [Related]
10. Estimating the risk of malignancy of adnexal masses: validation of the ADNEX model in the hands of nonexpert ultrasonographers in a gynaecological oncology centre in China.
He P; Wang JJ; Duan W; Song C; Yang Y; Wu QQ
J Ovarian Res; 2021 Dec; 14(1):169. PubMed ID: 34857005
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.
Van Calster B; Van Hoorde K; Valentin L; Testa AC; Fischerova D; Van Holsbeke C; Savelli L; Franchi D; Epstein E; Kaijser J; Van Belle V; Czekierdowski A; Guerriero S; Fruscio R; Lanzani C; Scala F; Bourne T; Timmerman D;
BMJ; 2014 Oct; 349():g5920. PubMed ID: 25320247
[TBL] [Abstract][Full Text] [Related]
12. Evaluating use of IOTA two-step strategy to classify adnexal masses identified in pregnancy: pilot study.
Barcroft J; Pandrich M; Del Forno S; Cooper N; Linton-Reid K; Landolfo C; Timmerman D; Saso S; Bourne T
Ultrasound Obstet Gynecol; 2024 May; ():. PubMed ID: 38787921
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.
Yoeli-Bik R; Longman RE; Wroblewski K; Weigert M; Abramowicz JS; Lengyel E
JAMA Netw Open; 2023 Jul; 6(7):e2323289. PubMed ID: 37440228
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance scoring system for assessment of adnexal masses: added value of diffusion-weighted imaging including apparent diffusion coefficient map.
Hottat NA; Van Pachterbeke C; Vanden Houte K; Denolin V; Jani JC; Cannie MM
Ultrasound Obstet Gynecol; 2021 Mar; 57(3):478-487. PubMed ID: 32438461
[TBL] [Abstract][Full Text] [Related]
15. Clinically oriented three-step strategy for assessment of adnexal pathology.
Ameye L; Timmerman D; Valentin L; Paladini D; Zhang J; Van Holsbeke C; Lissoni AA; Savelli L; Veldman J; Testa AC; Amant F; Van Huffel S; Bourne T
Ultrasound Obstet Gynecol; 2012 Nov; 40(5):582-91. PubMed ID: 22511559
[TBL] [Abstract][Full Text] [Related]
16. Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk.
Hidalgo JJ; Ros F; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana Á; Alcázar JL
Ultrasound Obstet Gynecol; 2019 May; 53(5):693-700. PubMed ID: 30353585
[TBL] [Abstract][Full Text] [Related]
17. Reliability of IOTA score and ADNEX model in the screening of ovarian malignancy in postmenopausal women.
Nohuz E; De Simone L; Chêne G
J Gynecol Obstet Hum Reprod; 2019 Feb; 48(2):103-107. PubMed ID: 29709594
[TBL] [Abstract][Full Text] [Related]
18. Benign descriptors and ADNEX in two-step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation in IOTA5 multicenter cohort.
Landolfo C; Bourne T; Froyman W; Van Calster B; Ceusters J; Testa AC; Wynants L; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Savelli L; Fischerova D; Czekierdowski A; Kaijser J; Coosemans A; Scambia G; Vergote I; Timmerman D; Valentin L
Ultrasound Obstet Gynecol; 2023 Feb; 61(2):231-242. PubMed ID: 36178788
[TBL] [Abstract][Full Text] [Related]
19. External validation of IOTA simple descriptors and simple rules for classifying adnexal masses.
Alcázar JL; Pascual MA; Graupera B; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana A; Hereter L; Ajossa S; Guerriero S
Ultrasound Obstet Gynecol; 2016 Sep; 48(3):397-402. PubMed ID: 26748432
[TBL] [Abstract][Full Text] [Related]
20. Performance of IOTA Simple Rules Risks, ADNEX Model, Subjective Assessment Compared to CA125 and HE4 with ROMA Algorithm in Discriminating between Benign, Borderline and Stage I Malignant Adnexal Lesions.
Czekierdowski A; Stachowicz N; Smolen A; Łoziński T; Guzik P; Kluz T
Diagnostics (Basel); 2023 Feb; 13(5):. PubMed ID: 36900029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
